The Tobramycin Study

NCT00257790 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

210

Enrollment

OTHER

Sponsor class

Conditions

Neutropenia
Fever
Cancer

Interventions

DRUG: Tobramycin once a day

Sponsor

Oslo University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]